(NASDAQ: SIBN) Si Bone's forecast annual revenue growth rate of 13.36% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.54%.
Si Bone's revenue in 2023 is $131,980,000.On average, 3 Wall Street analysts forecast SIBN's revenue for 2023 to be $5,531,832,226, with the lowest SIBN revenue forecast at $5,528,632,646, and the highest SIBN revenue forecast at $5,534,464,793. On average, 3 Wall Street analysts forecast SIBN's revenue for 2024 to be $6,566,835,869, with the lowest SIBN revenue forecast at $6,562,056,749, and the highest SIBN revenue forecast at $6,573,316,033.
In 2025, SIBN is forecast to generate $7,823,582,613 in revenue, with the lowest revenue forecast at $7,702,079,544 and the highest revenue forecast at $7,934,150,406.